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Mińczuk K, Li J, Kundu BK, Berr S,
Correcher C, Bahadur A,
Attarwala AA, Stark S, Junge S,
Himmelreich U, Prior JO, Laperre K,
Van Wyk S and Heidenreich M (2019)
Low-Dose Imaging in a New
Preclinical Total-Body PET/CT
Scanner. Front. Med. 6:88.
doi: 10.3389/fmed.2019.00088
Low-Dose Imaging in a New
Preclinical Total-Body PET/CT
Scanner
Cesar Molinos 1*, Todd Sasser 1, Phil Salmon 1, Willy Gsell 2, David Viertl 3,
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Ionizing radiation constitutes a health risk to imaging scientists and study animals. Both
PET and CT produce ionizing radiation. CT doses in pre-clinical in vivo imaging typically
range from 50 to 1,000 mGy and biological effects in mice at this dose range have
been previously described. [18F]FDG body doses in mice have been estimated to be
in the range of 100 mGy for [18F]FDG. Yearly, the average whole body doses due to
handling of activity by PET technologists are reported to be 3–8 mSv. A preclinical
PET/CT system is presented with design features which make it suitable for small animal
low-dose imaging. The CT subsystem uses a X-source power that is optimized for small
animal imaging. The system design incorporates a spatial beam shaper coupled with
a highly sensitive flat-panel detector and very fast acquisition (<10 s) which allows for
whole body scans with doses as low as 3 mGy. The mouse total-body PET subsystem
uses a detector architecture based on continuous crystals, coupled to SiPM arrays
and a readout based in rows and columns. The PET field of view is 150mm axial
and 80mm transaxial. The high solid-angle coverage of the sample and the use of
continuous crystals achieve a sensitivity of 9% (NEMA) that can be leveraged for use of
low tracer doses and/or performing rapid scans. The low-dose imaging capabilities of the
total-body PET subsystem were tested with NEMA phantoms, in tumor models, a mouse
bone metabolism scan and a rat heart dynamic scan. The CT imaging capabilities were
tested in mice and in a low contrast phantom. The PET low-dose phantom and animal
experiments provide evidence that image quality suitable for preclinical PET studies is
achieved. Furthermore, CT image contrast using low dose scan settings was suitable
as a reference for PET scans. Total-body mouse PET/CT studies could be completed
with total doses of <10 mGy.
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INTRODUCTION
Both positron emission tomography (PET) and computed
tomography (CT) imaging involves ionizing radiation producing
deleterious effects on study animals and constitutes a health
risk for researchers. Dose reduction efforts are important
in pre-clinical imaging for animal care and study integrity
considerations, especially where repeat scans will be performed in
longitudinal studies. Further, dose reduction efforts can also help
limit the exposure to human system operators. In humans, acute
radiation dose effects like skin redness, hair loss, radiation burns,
or acute radiation syndrome occur when doses exceed 1 Sv and
are delivered at high dose rates. Nevertheless, it is the increase
in cancer risk with low but continuous dose exposure that is
relevant in radiation exposed workers. Epidemiological studies in
humans point to a significant cancer risk increase for doses above
100 mSv (1). The regulation applied in more than ten European
countries prescribes the following dose limits: 1 mSv/year for
general population and up to 20 mSv/year for professionals. A
fundamental edict of dose reduction efforts is that exposures
should be kept ALARA (As Lows As Reasonably Achievable).
Efforts to reduce operator and patients’ exposure are
ongoing (2). Development of total-body PET systems (systems
providing simultaneous full body coverage) is receiving increased
interest owing not only for the potential to perform whole
body screening, capture simultaneous dynamic data for highly
quantitative kinetic imaging, but also because the large detector
design employed for total body coverage can provide higher
sensitivity (3). Total-body PET imaging can provide gains in
sensitivity owing to the expanded geometric coverage of the
detector design and higher rate of co-incident detections across
the axis. Further, total-body PET, in contrast to traditional whole-
body PET procedures using axial bed movement which requires
image stitching, can provide full sample coverage without
increasing total scan time.
CT doses for scans for livemice typically range between 50 and
800 mGy using current scanning technologies (4–7) CT doses
for studies of rodent bone metrics and other higher resolution
protocols used in for ex vivo imaging are commonly>1Gy (6, 7).
CT exposure and dose minimization have been a constant subject
of research over the years (8–18).
The scientific literature dealing with PET related doses to
small rodents is comparatively scarce. Taschereau et al. used
GATE, a Monte Carlo tool, to calculate the PET absorbed doses
employing an anatomically realistic 3Dmouse model comprising
25 organs and relevant structures (19). The spatial and time
distributions of tracer activity were measured through PET scans.
It was found that absorbed doses from many preclinical rodent
PET protocols can be higher than CT doses depending on activity
used and organ. Doses to mice were estimated to be around 100
mGy in the body and as high as 3.7Gy in the bladder in a typical
injection of 7 MBq. Bone marrow and brain doses for that same
injection would be around 70 and 100 mGy, respectively. The
authors show how doses arising from the PET preclinical imaging
procedure can lie well within the range of biological effects in
mice and these doses can exceed CT doses by significant margin
specially depending on the organ and the activity employed. They
recommend emptying the bladder as a standard practice in PET
imaging given the large doses.
These doses incurred during preclinical PET/CT scans values
are within a range where subclinical effects including DNA
breakage and effects on the immune system have been detected
(7). On CT imaging doses, Tang et al. report effects of continued
or chronic low dose rate on fertility, tumorigenesis and lifespan
(20). In addition, induced genetic and epigenetic changes are
found as well as cataractogenesis and abnormal neurogenesis
in the brain, impairment of neurogenesis and cerebrovascular
diseases, resulting in loss of cognitive functions. Tada et al.
reported effects in cell proliferation in the dentate gyrus of the
brain (21). Klinck et al. found bone architecture changes in
skeletally immature mice (14).
Of special relevance on PET/CT Oncology studies is the work
of Laforest et al. (9) and Daibes et al. (12) where reduced tumor
growth at doses of 60 mGy is reported. In particular Laforest
et al. (9) showed tumors receiving higher doses of 110 and 550
mGy would take longer to reach the control tumor sizes. This
tumor growth inhibition poses an important argument in favor
of protocols minimizing doses.
The exact significance of PET/CT related doses on the
animal models under study is complex, but evidence points
to influence on the viability of some rodent disease models
and bias introduced for the interpretation of the data
involving therapeutics.
There are multiple reports covering radiation doses to clinical
PET technologists (22–24). In some cases, average annual whole-
body doses are reported to be around 3 mSv (22) and in others
with high throughput facilities, doses are reported to be around
8 mSv (23). Total exposure varies in relation to the total amount
of tracer handled as well as differences in dose preparation and
workflows. Demir et al. reported a reduction in doses to 6 mSv
after implementing extra radiation shielding (23).
Scientific literature covering doses to pre-clinical PET
technologists or researchers is not abundant. However, Prevol
et al. report on doses from SPECT imaging with 111I (25). In this
study, whole-body doses and doses to extremities are comparable
to those from the clinic. Interestingly, it is also reported that some
of the activities intrinsic to small animal research, like animal
dissection, lead to the highest exposures.
Dose per activity coefficients found in clinical studies (22,
23) could suggest a way of estimating doses to pre-clinical
PET operators but procedures and isotopes will differ between
the clinical and pre-clinical environments, so the result might
be unreliable. The fact that lower doses are injected to small
rodents than to human patients suggests that doses to pre-clinical
operators will be lower. Nevertheless, research labs will operate
in less prescriptive workflows than clinical practice and the
range of PET isotopes used in research labs will surely be larger
than in clinics where [18F]FDG will be the dominant isotope.
Furthermore, in the preclinical environment, despite that the
injected doses will be lower, the vial handled to fill the syringes
will contain activity amounts as large as in the clinic. Assuming
a hypothetical but realistic high throughput laboratory case of
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4 studies per day and 200 annual working days, this leads to
800 studies annually. Taking a 4.1 uSv per study from (22) this
would result in approximately 3 mSv annual dose. If the 14 uSv of
shallow dose per injection from (24) is used for the same annual
work, this would lead to around 11 mSv.
Like in the clinic, strategies to optimize workflows can
minimize these dose exposures, but ultimately tracer activity
reduction can provide a reliable means to reduce operator
exposures. Low-dose PET imaging has the advantage that more
animals can be imaged given a certain amount of tracer which




An integrated total-body PET/CT system, the Si78, with low-dose
capabilities was developed by Bruker Biospin GmbH (Ettlingen,
Germany) (see Figure 1). The PET Si78 features a detector
architecture based on continuous crystals, coupled to silicon
photomultiplier (SiPM) arrays and a readout based in rows and
columns (26). A 10mm thick Lutetium Yttrium Oxyorthosilicate
(LYSO) crystal has the shape of a truncated pyramid with a 50
× 50mm base and a 48 × 48mm top side. Eight of these units
are used to construct an octagonal ring. The transaxial field of
view is 80mm and can be configured with up to three rings for
an axial field of view of 150mm (Figure 2). The sensitivity of
the total body PET detector design matches or exceeds that of
other current preclinical scanners. Cal-Gonzalez et al. (27) report
on a number of existing systems with around 9% sensitivity. The
row and column readout approach reduces the amount of SiPM
signals that need acquiring from 12 × 12 signals to 12+12. This
detector design allows for the characterization of scintillation
light pulses which in turn are used to measure the depth of
interaction in the crystal, achieving a ≤1.2mm resolution across
the field of view. The high solid angle coverage of the sample and
the use of continues crystals achieves a NEMA (28) sensitivity of
9% which in turns allows the minimization of injected activity
or scan time. The FPGA based DAQ electronics is capable of
simultaneously acquiring a total of 768 detector analog signals
achieving a NEMA mouse noise equivalent count rate (NECR)
≥ 500 kcps. The Si78 PET subsystem (detectors and DAQ) has
been used in a PET/SPECT/CT platform (Albira Si) as well as
in a number of PET/MR platforms. These PET/MR platforms
are a PET Insert for simultaneous high field magnetic resonance
imaging (MRI) and a PET module present in the PET/MRI 3T
system which can also be attached to high-field MRI systems for
sequential PET and MRI.
The PET acquisition and reconstructions settings used were
all typical of animal work and available on the default software
configuration. The energy window employed was 511± 153 keV
(i. e., 511 keV± 30%).
Radiation dose in microCT imaging is dependent on three
main factors; the x-ray source voltage and current, the distance
between the x-ray source and the object (SOD), and the
filtration method used. The CT submodule was designed to
minimize the radiation dose applied to the animal by using
a combination of these factors, and by using additional dose-
minimizing components to achieve fast scanning down to <8 s
withminimal compromise in image quality. First, an x-ray source
with a maximum voltage of 65 kV and power of 50W is used
providing sufficient flux to capture images at a very fast rate. The
system is equipped with a flat panel CMOS sensor which has
relatively fast frame rates at down to 10ms. Second, the system is
equipped with a set of filters, including a low-dose beam shaper
filter, whichmodify and optimize the x-ray absorption to best suit
the animal size that is being scanned.
In 3D CT imaging, there is a redundancy of information
collected from the center of the sample. This information tends
to be wasted or not used efficiently during the reconstruction
process. The low dose beam shaper filter reduces the radiation
dose by filtering more x-ray photons from the center of the
image which has redundant information and gradually decreases
the filtration toward the periphery (see Figure 3). This helps to
reduce the radiation dose to the animal by a factor of 2-5 and as
low as 3 mGy.
Very low doses can also be achieved using the standard
aluminum filters and optimized settings of camera exposure
times and source power. The CT subsystem is also used in
a standalone CT platform; SkyScan 1278 (Bruker microCT,
Kontich Belgium). This CT system has been used for low-
dose imaging in studies of skeletal development in mouse pups,
in studies of adipose tissue segmentation, and in studies of
pulmonary fibrosis. The system has also been used to assess
the scan and dose limits where even subclinical radiation
dose effects are not incurred (Prof. Vande Velde, KU Leuven,
personal communication). Examples of other applications can
be found in Xuan et al. (29), Broucke et al. (30) and
Covarrubias et al. (31).
PET Phantom Experiments
Preclinical PET imaging is considered to be the gold standard
for quantitative in vivo studies. Preclinical PET studies often
aim to quantitatively assess new tracers and assess candidate
therapeutics through measurement of biomarkers of a range
of diseases including cancer and neurological disorders. Tracer
activities typically reported in preclinical studies range from 5 to
40 MBq.
Initial phantom experiments were performed to assess the
data integrity, relevant to common preclinical studies, when
imaging low tracer activities using a preclinical total-body
PET/CT system.
To assess ability of the PET system to accurately distinguish
small activity difference in low-dose imaging a NEMAmouse size
scatter phantom was loaded with 925 kBq [18F]FDG and imaged
over 60 min.
The NEMA Image Quality Phantom was used to assess
the uniformity, recovery coefficients for the different rod
sizes as well as the spill over ratio for water and air. The
phantom was loaded with 1 MBq [18F]FDG and after 10min,
a static acquisition of 20min was performed. The IQ phantom
acquisition was reconstructed with the maximum likelihood
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FIGURE 1 | The new PET/CT “Si78”.
FIGURE 2 | High sensitivity total-body PET detector design. Mouse inside field of view.
FIGURE 3 | Novel X-ray beam shaper for low-dose imaging.
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expectation maximization (MLEM) algorithm using 25 iterations
and a voxel size of 0.5mm. In addition, a point spread function
iterative deconvolution based Partial Volume Correction (PVC)
was employed (32).
To assess the spatial resolution in low dose imaging
employing realistic laboratory conditions a micro-Derenzo type
phantom was loaded with 3 MBq and acquired for 20min. The
reconstruction settings employed were also equivalent to those
typically employed in animal experiments: MLEM algorithm, 30
iterations, voxel size of 0.25mm and PVC activated.
PET in vivo Experiments
Preclinical PET is used widely in studies of tumor biology
and tumor progression. Such studies often aim to measure
quantitative changes in tumor biomarkers. Initially, the low
dose imaging capabilities of the total-body PET subsystem were
tested as part of an ongoing breast cancer model experiment
in mice. Here only one mouse was imaged as a preliminary
study to investigate the viability of this technique. As a
further low dose imaging test, 2 mice were imaged as part
of an ongoing fibrosarcoma experiment. In both experiments,
data was assessed for contrast, resolution, and quantitative
integrity critical for small animal tumor studies. On the breast
cancer model, an immunodeficient BALB/c nude female mouse
was imaged 10 days after MCF-7 breast cancer cells were
grafted being the animal 7 weeks old. The mouse drank water
supplemented with β-estradiol. On the fibrosarcoma experiment,
two immunodeficient BALB/c nude female mice were imaged 10
days after SK-N-AS fibrosarcoma tumor cells were grafted being
the animals 7 weeks old. In both experiments, acquisitions were
carried out 70min after the injection of 1 MBq of [18F]FDG and
lasted 60min. The whole of the list-mode file was rebinned in
10min frames and an image was reconstructed out of each frame.
The PET image reconstruction settings were: MLEM algorithm,
24 iterations and a 0.5mm voxel size.
The [18F]FDG dose/MBq coefficients obtained by Taschereau
and Chatziioannou (19) for the body, brain and bone are 14, 13,
and 5 mGy/MBq, respectively. For the radiosensitive organs like
testes and thyroid, these coefficients were 16 and 14, respectively.
The bladder was the organ with the largest dose value with over
500 mGy/MBq. The dose/MBq coefficient for the body was used
to derive the dose due to the PET procedure in this experiment.
Researchers are commonly employing multi-animal beds and
simultaneous imaging to increase preclinical PET throughput.
Three C57BL/6 female mice were imaged simultaneously using
a low-dose protocol using the [18F]NaF tracer. Animals received
2 MBq [18F]NaF and were scanned 40min post injection. List-
mode data was reconstructed at variable effective scan times to
determine the minimum acceptable scan time. The list-mode file
was divided in 1min frames and reconstructed at low resolution
to check whether the animals had remained still. Twenty minutes
into the acquisition the animals had remained still for 18min
whereas in the rest of the acquisition there had been somemotion
of tails, spine and bladder causing significant blurring. Uptake
time at the start of the selected list-mode frame had been 1 h
and each of the animals had an activity of 1.3 MBq in the mid-
point of the frame. The selected 18min were reconstructed with
using MLEM, 24 iterations and a voxel of 0.25mm. PVC (32)
was applied and the final image was filtered using a Median 3D
algorithm with a 1.0mm isotropic kernel.
In the case of fluoride ion, the dose/MBq coefficients obtained
by Taschereau and Chatziioannou(19) for the body, brain and
bone are 10, 13, and 76 mGy/MBq, respectively. Testes and
thyroid were 9 and 5, respectively with the bladder getting over
300 mGy/MBq. The dose/MBq coefficient for the body was used
to derive the dose due to the PET procedure in this experiment.
Dynamic PET imaging is a tool for testing and validating
tracer kinetic modeling. Tracer kinetic modeling is a method
for extracting transfer rate constants, volumes of distribution
or binding potentials from the radiotracer to the target, by
describing themechanism of transport and biochemical reactions
of the tracer in tissue. Blood samples are often taken from the
animal to obtain the so-called input function. This is compared
to the PET image to obtain the dynamics of the radiotracer
concentration in local tissue over time.
A further PET experiment using a control Wistar Kyoto
(WKY) was also carried out to investigate the applicability of
low dose imaging in [18F]FDG dynamic cardiac imaging. The
imaging protocol was similar to already published work in mice
and more recently in rats (33–35). The rat was fasted for 5–6 h
with free access to water prior to [18F]FDG imaging. A 60min
dynamic PET data acquisition was initiated a few seconds before
the slow (over 10-20 s) administration of 2.7 MBq [18F]FDG
via a tail-vein catheter. Blood samples were also collected from
tail-vein right of the rat after PET/CT scan in a volume of
0.36ml, which were then weighed and radioactivity measured
using a Hidex Automatic Gamma Counter. The decay corrected
blood sample measurement at 56min was used for validation of
model corrected blood input function at the same time point,
as described (34, 35). The list-mode data was sorted into 23
time bins and reconstructed with attenuation correction using
MLEM algorithm with 6 iterations and 0.75mm isotropic voxel
resolution. Region of interest (ROI) analysis and computation
of myocardial FDG uptake rate, Ki, was performed as described
(33–35). Data representing [18F]FDG concentrations in the
myocardium and left ventricle were taken from two ROIs in a
single frame of the 4-D dynamic PET image. The slices from
the last time frame of the image were manually parsed until the
left ventricle was clearly visible. Once a slice in the midsection
of the heart was identified, the two ROIs were manually drawn
as continuous lines using a series of connected points. Time
activity curves (TAC) for each of the two ROIs were generated by
averaging the image data of a given ROI at each time frame. Due
to the intrinsically limited spatial resolution offered by PET as an
imaging technique and the small size of rat heart, partial volume
(PV) averaging can become a significant problem resulting in
spill over contamination (SP) from the blood to the tissue at early
and vice-versa at late time points. Using the formalism developed
in Zhong et al. (33), Zhong and Kundu, (34), Li et al. (35), and
Li and Kundu. (36), a 3-compartment kinetic model that can
simultaneously correct for SP and PV effects for both the blood
pool and myocardium, generate a model corrected blood input
function (MCIF) and compute kinetic rate parameters (K1-k3),
was used to compute rate of myocardial FDG uptake, Ki (35).
Frontiers in Medicine | www.frontiersin.org 5 May 2019 | Volume 6 | Article 88
Molinos et al. Low-Dose Imaging Total-Body PET/CT
The above analysis was performed using the MATLAB_r2018a
(Mathworks Inc., Natick MA) computing environment.
Given the absence of appropriate dose/MBq coefficients for
rats, doses were not calculated in this experiment.
CT Dose Calculations and Measurements
The Bruker’s software CTion 1.0 was used for the calculations.
The calculation of X-ray dose in CTion is based on the
simulations of X-ray photon energy spectra and dose by the
program SpekCalc (37–39). X-rays are assumed to be emitted
from an X-ray source using a tungsten target, as used on the
Si78. CTion calculates dose rates in mGy/min in air, for a rat and
for a mouse once the user inputs these values: current, voltage,
distance source to sample and type of filtering.
In order to assess the accuracy of the calculations, dose
measurements were also carried out with a MOSFET type
dosimeter. In particular, the Unfors Patient Skin Dosimeter was
used for the measurements. This features two MOSFET (Metal
Oxide Semiconductor Field Effect Transistor) detector heads, one
is in air to measure air dose, the other was shielded by a white
PMMA tube with overall thickness about 25mm to estimate
depth-corrected dose in a mouse.
CT Phantom Experiments
In order to assess tissue contrast obtained with CT settings which
would suffice for a PET scan anatomical reference, a low contrast
CT phantom (QRM) was scanned at a range of settings. Dose
estimates were derived from simulations by CTion.
Furthermore, to assess the general CT image quality and
specifically uniformity in low dose imaging, a phantom consisting
of a water tube was scanned at two different resolutions, 200 and
100 micron resolution. The CT settings were such to mimic the
typical conditions in a preclinical PET/CT experiment.
CT in vivo Imaging of a Wild Type Mouse
A first experiment was designed to achieve the best image
quality possible while minimizing the dose. An adult wild type
mouse was scanned using a Low Dose 1mm Al filter at 39 kVp
and with varying current and acquisition times to progressively
lower the dose and assess the resulting image quality. Keeping
the current at 199µA, two scans were performed for 149
and 84 s, respectively. Then, lowering the current to 69µA,
two scans were performed for 91 and 44 s, respectively. The
exposure time was kept at 300ms. The data was reconstructed
using the filtered back projection (FBP) algorithm and standard
reconstruction parameters.
In a second experiment, an adult wild typemouse was scanned
minimizing both acquisition time and dose. The settings were 54
kVp, 900µA and 7 s of total scan time resulting in a 200 um pixel
resolution image. The option to scan using “continuous mode”
instead of “step and shoot” was used to achieve the fast scan




Quantitative assessment of the low activity during the decay
period in the mouse NECR phantom revealed that subtle
difference in activities could be distinguished and that measured
values were consistent with expected results (see Figure 4).
Figure 5 shows the IQ Phantom with a transversal slice
through the SOR region of the phantom and another one through
the capillaries. Tables 1A–C show the numerical analysis of the
IQ phantom. NEMA Image Quality with PVC (Partial Volume
Correction) shows recovery coefficients close to 1.0 for all
fillable rod sizes but the 1mm size rod (Table 1B). Nevertheless,
resulting standard deviations are relatively high.
PVC has therefore a positive effect bringing the 2, 3, and 5mm
rods recovery coefficients closer to 1.0, especially the 2mm rod.
However, an increase in image noise is also observed when PVC
is applied. This is especially evident from the uniformity results
(Table 1A), where ideally there is no influence of partial volume.
Figure 6 shows the resulting image of the micro-Derenzo
type phantom experiment. Capillaries in the diameter range
of 0.9–1.2mm are well resolved highlighting the possibility of
submillimetric resolutions even in low dose animal experiments.
PET in vivo Experiments
To evaluate the system for use in low-dose preclinical PET
imaging one mouse with a breast tumor and two mice with a
fibrosarcoma tumor model were employed. When the %ID/mL
calculated from the last frame image was compared with the
rest of frames, and also with the whole list-mode file image,
this showed a good agreement. The image of this last frame
also showed adequate quality tumor uptake was 11 %ID/mL for
the breast model and around 13 %ID/mL for the fibrosarcoma
model. Figure 7 shows mouse 1 of the fibrosarcoma experiment.
By using the Dose/MBq conversion coefficient explained in
Taschereau and Chatziioannou (19) the whole-body dose due to
the PET procedure was estimated to be 14 mGy but based on
the results obtained here this could likely be lowered to at least
7 mGy. The activity in the midpoint of the last frame was 452
kBq and this suggests that injected doses can at least be halved
and should not affect the experiment results significantly.
These results suggest the possibility of using low dose
injection in this particular tumor model. Nevertheless, more
animals would have to be imaged to make the result statistically
significant. Also, it is still to be seen the applicability of low dose
imaging for both other tumor models as well as other tracers.
Figure 8 shows the resulting MIP image for the total body of
all 3 mice.
Using the provided dose activity conversion coefficient of 10
mGy/MBq (19) for fluoride ion therefore it can be estimated that
each of the animals received a dose of 20 mGy just from their
injection. The total dose to each of the animals in this multiple
animal experiment will nevertheless be higher given the external
irradiation from the neighboring animals. The images show that
sufficiently good resolution is achieved in low dose experiments
in acquisitions lasting <20 min.
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FIGURE 4 | Mouse NECR Phantom [18F]FDG starting 925 kBq signal quantified over 60-min decay.
FIGURE 5 | IQ Phantom images acquired over 20 min with <1 MBq.
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TABLE 1 | NEMA IQ results.
A. Uniformity
Mean Maximum Minimum Std (%)
PVC OFF 49.2 kBq/ml 71.7 kBq/ml 32.2 kBq/ml 9.6
PVC ON 49.2 kBq/ml 94.9 kBq/ml 14.2 kBq/ml 19.6
B. Recovery Coefficients. Standard Deviation in % Within Brackets
1 mm 2 mm 3 mm 4 mm 5 mm
PVC OFF 0.04 (28.5) 0.68 (17.3) 0.88 (13.3) 1.00 (15.5) 0.96 (15.5)
PVC ON 0.04 (52.8) 0.92 (30.6) 1.02 (26.3) 1.13 (25.6) 1.03 (30.7)
C. Spill Over Ratio. Standard Deviation in % Within Brackets
Air Water
PVC OFF 0.17 (35.0) 0.25 (23.0)
PVC ON 0.16 (42.9) 0.25 (35.1)
FIGURE 6 | micro-Derenzo phantom imaged for 20min with 3 MBq of
[18F]-FDG. Capillary sizes in mm are shown in the image.
Figures 9A–E shows representative dynamic [18F]FDG PET
coronal images for the rat heart in vivo experiment at an
early time frame (20 s), and at 1, 10, 30, and 56min post
[18F]FDG injection. The latest time frame most clearly showed
the myocardium, see Figure 9E, since most [18F]FDG had
been taken up from the blood by that time point. Figure 9F
shows representative time activity curves for LV blood pool
and myocardium, model fits, and MCIF. The MCIF at 56min
agrees with a blood sample (8.67 kBq/cc) at the same
time point.
This experiment has shown the feasibility of low dose
imaging also in the context of dynamic [18F]FDG PET
with rats.
CT Doses Calculation and Measurement
For the setting of 40 kV, 500µA, and 1mm Al filtration, the
absorbed X-ray dose calculated by CTion, in air and averaged
over a mouse of 25mm diameter, were 47.95 and 26.07 mGy/min
respectively. With these same settings the doses measured by
the MOSFET Patient Skin Dosimeter, in air and shielded by
about 25mm thickness of PMMA, were 44.5 and 20.0 mGy/min
respectively. Thus, the deviation between the doses calculated
by emission simulation and measured by MOSFET detector,
were 8 and 30% for the dose in air and the dose depth
corrected for mouse, respectively. Generally, it was observed
that for lower voltages and filtering the MOSFET-measured
values were lower than the simulated values. The contrary
was observed with higher voltages. The agreement for 50 kV
was within 10% on both air and mouse doses. This could
be explained by the decrease of detection efficiency of the
MOSFET type dosimeter detectors employed, with decreasing
photon energies below about 30 keV X-ray photon energies
in CT imaging, even with aluminum filtration, extend down
to 10–15 keV. The CT settings in typical PET/CT experiment
use step and shoot and a 200µA current so based on the
results above, the dose to mouse scales linearly with current and
therefore can be estimated to 10 mGy/min. Air doses would be
around 19 mGy/min.
CT Phantom Experiments
Figure 10 shows how imaging of a low contrast phantom reveals
sufficient contrast to detect 2.5mm rods. Rods were imaged
from seconds to minutes and using variable (time, Al filter,
current, and voltage). Contrast for phantom imaging can be
enhanced further (not shown) with modified settings, with
modest increases in dose.
The water tube phantom experiment was carried out using
the step and shoot mode and employed the low dose settings:
40 kV, 200µA, 1mm Al filter and 300ms exposure time. Those
are estimated to be in the 10–15 mGy range. Each acquisition
took just over 1min of scan time. Figure 11 shows the resulting
uniform artifact free images.
CT in vivo Imaging of a Wild Type Mice
Figure 12 shows the sagittal view of the mouse imaged with 4
different settings in which dose is reduced from a starting point
of 26, then to 15, 16 and finally 3 mGy approximately. It can be
seen how skeletal and tissue contrast decreases as dose goes down
but stays even in the 3 mGy case sufficiently good for anatomical
reference in small animal PET scans. Figure 13 shows the 26 and
3mGy cases next to each other including all three coronal, sagittal
and transversal views.
This experiment shows how with 40 kV and 1mmAl filtering,
low dose images of enough quality can be obtained in less than a
minute by using relatively long exposure times (e.g., 300ms) and
low current.
Figure 14 shows the result of the experiment to minimize
not only dose but acquisition time. The image shown is the
result of a 7 s scan time and the dose is calculated to be less 10
mGy. Again, dose reduction settings provide sufficiently good
contrast for skeletal structure, as well as lower contrast soft
tissue organs.
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FIGURE 7 | Mouse 1 of fibrosarcoma tumor model. Top: Tumor is marked by white arrow and heart by red arrow. Contrast and resolution are sufficient to resolve
heterogenous tumor uptake, see orange arrow. Bottom: Low-dose total-body [18F]FDG/PET with clearly defined tumor uptake and contrast. Tumor uptake
measurements (13% ID/mL) obtained fall within typical ranges for this model. Results for 10-minute and 60-minute scans are consistent, indicating that low-dose
imaging even for 10 minutes provides sufficient counts for reliable data and quantifications.
DISCUSSION AND CONCLUSIONS
Low-dose imaging protocols in phantoms and animals were used
in the Si78, a new preclinical total-body PET/CT system.
CT imaging serves as an anatomical reference for functional
PET detections using integrated PET/CT systems. Anatomical
detections are critical for localizing PET signal and providing a
backdrop for accurately defining regions of interest for analysis.
The Si78 CT subcomponent was assessed for contrast and image
quality using low-dose protocols. Low-dose imaging provided
sufficient contrast to resolve tissue contrast to serve as an
anatomical reference for small animal PET scans.
Given that low-dose PET imaging can be performed with
doses <4 times lower relative to standard protocols, system
operators can benefit from reduced accumulative annual dose
exposures simply through reduced dose handling. This could be
particularly critical in core facilities where dedicated personnel
perform much of the scanning and tracer handling for an
institution. The new instrument allows for total-body mouse
PET/CT studies with doses of <10 mGy for each the PET and
CT procedures, minimizing animal dose exposures.
Low-dose PET imaging was shown to provide not only
qualitative features valued in functional imaging studies, but
contrast, resolution and quantitative features typical of standard
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FIGURE 8 | PET MIP images showing bone tracer Na[18F]. Arrows point to visible ribs as an indication of good resolution. Tracer uptake time was 1 h and scan time
18min. Each of the animals had been injected with 2 MBq.
protocols. Low-dose PET imaging in a preclinical tumor model
provided suitable resolution and quantitative measurements.
Often, studies aim to identify unique features of tumor
microenvironment that are believed to be critical to the
progression of many tumors. Regional changes in stromal tissues,
metabolics, and receptor expression are believed to be indicative
of such processes. Significantly, image resolution was sufficient to
distinguish intratumor metabolic heterogeneities, indicating that
low-dose imaging in this system will be suitable for interrogating
tumor biology critical for tumor progressions. Given that
preclinical PET imaging is often used to make quantitative
measurements of various molecular and cellular processes, low-
dose PET protocols should provide linear quantitative detections.
Linear dose decay measurements at <1 MBq in a mouse
phantom demonstrated that even subtle concentration difference
could be distinguished, providing evidence that quantitative
measurements at low doses are not compromised.
Further, low-dose multi-animal imaging using [18F]NaF
demonstrated that fine details of bone metabolism could be
resolved, providing further evidence that low-dose imaging can
provide total-body contrast sufficient for resolving details across
all anatomies covered in a total-body scan. One of the key
benefits for total-body PET imaging is the ability to collect
total-body dynamic data appropriate for highly quantitative
kinetic modeling that surpass traditional semiquantitative SUV
measurements. Total-body high resolution demonstrated here
would indicate that imaging at both local and distant anatomies
could be employed for total-body kinetic modeling studies.
The rat heart dynamic PET experiment has also shown the
feasibility of low dose imaging for such an application.
Low-dose high-sensitivity PET imaging provides several
cost-saving and performance benefits beyond simple reduction
in exposures to ionizing radiation. Low-dose PET imaging can
be particularly valuable in studies of new candidate tracers.
Often, development of candidate tracers can be costly where
tracer chemistries and ligand development may be made in an
iterative process. Low-dose PET imaging can be useful because
it allows for testing of very low-volume and low-activity tracers
and tracer performance is validated and production is scaled.
In fact, even for routine imaging using established tracers,
low-dose imaging allows researchers to reduce costs related
to tracers. Low-dose (high sensitivity imaging) can also be
useful for sensitive cell tracking studies. Further, high-sensitivity
imaging can alternatively be used to reduce total exposure
times when standard tracer activities are used, resulting in gains
in throughput.
Low-dose CT imaging in mice demonstrated that suitable
tissue contrast and resolution were achieved. Using a
combination of dose minimizing energies and hardware,
including a beam sharping filter, supply suitable images/data.
Anatomical scanning could be achieved with total doses that were
well below even limits of subclinical effects, providing absolute
confidence for researchers that results/conclusions will not be
compromised by scanning protocols and as of yet undetermined
effects of subclinical effects of X-ray exposures on sensitive
disease models. Further, the CT scanning and reconstruction can
be completed at high-throughput (<10 s ) suitable for screening
multiple cohorts of animals commonly used in studies of new
therapeutics. Significantly, the CT subsystem also provides
features (self-gated cardiac and respiratory imaging) and
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FIGURE 9 | (A–E) Dynamic FDG PET images: Representative images at 20 s, 1, 10, 30, and 56min post FDG administration. (F) Time activity curves: Representative
time activity curves for LV blood pool and myocardium, model fits, and model corrected blood input function (MCIF). The MCIF at 56min agrees with a blood sample
(8.67 kBq/cc) at the same time point.
FIGURE 10 | Contrast phantom to evaluate contrast at low-doses (A) Scan time: 140 s and dose 12.5 mGy (B) 57 s and 9.9 mGy (C) 7 s and 5.8 mGy.
flexibility that could also be used for many dedicated CT scanner
applications including skeletal and bone measurements (e.g., rat
OVX osteoporosis models), cardiac and pulmonary disease, and
tissue segmentation (e.g., metabolic disease) protocols.
Radiation and dose exposures reduction efforts are critical
in medical/research imaging. Multiple researchers are actively
engaged in the development of clinical total-body PET
hardware. Human total-body PET promises improvements
in dose reductions, reduced scan times, and quantitative
kinetic modeling capabilities. Here, we have demonstrated
that total-body PET imaging in preclinical imaging may offer
many of the same benefits. Further, when combined with a
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FIGURE 11 | Water tube phantom scanned with 200 um resolution (left) and 100 um (resolution) in low dose setting mode.
FIGURE 12 | (A–D) Above show the 4 sagittal views with current and acquisition time settings such that approximately the dose is halved starting at 25.8 and
finishing at 2.6 mGy.
low-dose CT system, dose and throughput benefits can be
further enhanced.
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FIGURE 13 | Mouse scanned at 39 kV and aluminum filtering of 1mm. (a) On the left with typical imaging settings and (b) on the right, current and scan duration
optimized to minimize dose.
FIGURE 14 | Mouse imaged with 54 kVp, 900µA, and an acquisition time of 7 s and dose <10 mGy. The image voxel is 200 um.
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